One third of lymphoma patients cancer free after 6 months in CAR-T gene therapy study – Genetic Literacy Project
Genetic Literacy Project |
One third of lymphoma patients cancer free after 6 months in CAR-T gene therapy study
Genetic Literacy Project In all, 82 percent of patients had their cancer shrink at least by half at some point in the study. Its sponsor, California-based Kite Pharma, is racing Novartis AG to become the first to win approval of the treatment, called CAR-T cell therapy, in the … |
